Home » Topics » BioWorld Science

BioWorld Science
RSS

Neuprex enters pivotal trials

Oct. 18, 1996

Bristol-Myers Squibb obtains rights to Kyorin antibiotic

Oct. 18, 1996

Proceedings report improved patient outcome with ADCON-L

Oct. 18, 1996

Pfizer discloses polycyclic ether antibiotics

Oct. 18, 1996

Patent coverage for Demeter BioTechnologies wound-healing proteins

Oct. 18, 1996

New antimigraine agents disclosed by Merck & Co.

Oct. 18, 1996

Faulding to distribute Carrington's hydrogel wound dressings

Oct. 18, 1996

Barr re-introduces generic drug for pain

Oct. 18, 1996

Tentative FDA approval for generic analgesic

Oct. 18, 1996

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...